Human Amphiregulin DuoSet ELISA

• Supplier: R&D Systems
• Catalog: DY262
• Category: ELISA Kit
• Prices: $649.00
• Sizes: 1 kit (for 15 Plates)
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: 100 µL
• Range: 15.60 - 1,000 pg/mL
• Format: 96-well strip plate
• Applications: ELISA
• Gene: AREG

Product References

Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic - Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic

Breshears LM, Gillman AN, Stach CS, Schlievert PM, Peterson ML. PLoS One. 2016 Jul 14;11(7):e0158969.

Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts - Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts

Gao J, Ulekleiv CH, Halstensen TS. J Exp Clin Cancer Res. 2016 Sep 26;35(1):151.

ADAM17 substrate release in proximal tubule drives kidney fibrosis. - ADAM17 substrate release in proximal tubule drives kidney fibrosis.

Kefaloyianni E, Muthu ML, Kaeppler J, Sun X, Sabbisetti V, Chalaris A, Rose-John S, Wong E, Sagi I, Waikar SS, Rennke H, Humphreys BD, Bonventre JV, Herrlich A. JCI Insight. 2016 Aug 18;1(13). pii: e87023.

Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive - Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive

Aderhold C, Faber A, Umbreit C, Birk R, Weiss C, Sommer JU, Hormann K, Schultz JD. Anticancer Res. 2015 Apr;35(4):1951-9.

An integrative analysis of the tumorigenic role of TAZ in human non-small cell - An integrative analysis of the tumorigenic role of TAZ in human non-small cell

Noguchi S, Saito A, Horie M, Mikami Y, Suzuki HI, Morishita Y, Ohshima M, Abiko Y, Mattsson JS, Konig H, Lohr M, Edlund K, Botling J, Micke P, Nagase T. Clin Cancer Res. 2014 Sep 1;20(17):4660-72.

Autocrine ligands of the epithelial growth factor receptor mediate inflammatory - Autocrine ligands of the epithelial growth factor receptor mediate inflammatory

Parnia S, Hamilton LM, Puddicombe SM, Holgate ST, Frew AJ, Davies DE. Respir Res. 2014 Feb 20;15:22.

Aberrantly activated AREG-EGFR signaling is required for the growth and survival - Aberrantly activated AREG-EGFR signaling is required for the growth and survival

Chen Z, Chen J, Gu Y, Hu C, Li JL, Lin S, Shen H, Cao C, Gao R, Li J, Ha PK, Kaye FJ, Griffin JD, Wu L. Oncogene. 2014 Jul 17;33(29):3869-77.

Activation of HER family signaling as a mechanism of acquired resistance to ALK - Activation of HER family signaling as a mechanism of acquired resistance to ALK

Tanizaki J, Okamoto I, Okabe T, Sakai K, Tanaka K, Hayashi H, Kaneda H, Takezawa K, Kuwata K, Yamaguchi H, Hatashita E, Nishio K, Nakagawa K. Clin Cancer Res. 2012 Nov 15;18(22):6219-26.

A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor - A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor

Breshears LM, Schlievert PM, Peterson ML. J Biol Chem. 2012 Sep 21;287(39):32578-87. Epub 2012 Jul 25.

Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model - Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model

Richards FM, Tape CJ, Jodrell DI, Murphy G. PLoS One. 2012;7(7):e40597.